V L Yu, G E Wagner, S Shadomy. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Abducens NerveAdultAmphotericin B/administration & dosageAmphotericin B/therapeutic useAntifungal Agents/administration & dosageAspergillosis/complicationsAspergillosis/drug therapyBlindness/etiologyDrug Therapy, CombinationFlucytosine/administration & dosageHumansMaleOculomotor NerveOrbitParanasal Sinus Diseases/drug therapyParanasal Sinus Diseases/etiologyParanasal Sinus Diseases/surgeryPeripheral Nervous System Diseases/drug therapyPeripheral Nervous System Diseases/etiologyRifampin/administration & dosageSphenoid Sinus/surgery
Substances: See more » Antifungal AgentsAmphotericin BFlucytosineRifampin
Year: 1980 PMID: 6248652
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272